Cargando…
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
PURPOSE: SAMHD1 is a deoxynucleotide triphosphate (dNTP) triphosphohydrolase which has been proposed as a putative prognostic factor in haematological cancers and certain solid tumours, although with controversial data. Here, we evaluate SAMHD1 function in ovarian cancer, both in vitro and in ovaria...
Autores principales: | Gutiérrez-Chamorro, Lucía, Felip, Eudald, Bernat-Peguera, Adrià, Ezeonwumelu, Ifeanyi Jude, Teruel, Iris, Martínez-Cardús, Anna, Clotet, Bonaventura, Riveira-Muñoz, Eva, Romeo, Margarita, Margelí, Mireia, Ballana, Ester |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948397/ https://www.ncbi.nlm.nih.gov/pubmed/36845138 http://dx.doi.org/10.3389/fimmu.2023.1112761 |
Ejemplares similares
-
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
por: Castellví, Marc, et al.
Publicado: (2020) -
Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713
por: Castellví, Marc, et al.
Publicado: (2020) -
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types
por: Felip, Eudald, et al.
Publicado: (2022) -
Role of ctDNA in Breast Cancer
por: Sant, Marta, et al.
Publicado: (2022) -
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection
por: Ezeonwumelu, Ifeanyi Jude, et al.
Publicado: (2022)